NCT06757829 Pulmonary Functions in Sickle Cell Disease: Response to Acu-TENS
| NCT ID | NCT06757829 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Sickle Cell Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-12-15 |
| Primary Completion | 2025-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-12-15 with a primary completion date of 2025-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
pulmonary complications are common in sickle cell disease patients. Respiratory training using inspiratory muscle trainer (IMT) is usually a good choice to improve these complications. Recently, acupuncture like transcutaneous electrical nerve stimulation (AC-tens) may also improve these complications.
Eligibility Criteria
Inclusion Criteria: * sickle cell disease patients * non obese patients Exclusion Criteria: * patients with any systemic or chest or renal or hepatic or neurological diseases * women with lactation or pregnancy * patients atacks of vasoocclusive crisis
Contact & Investigator
Ali Ismail, lecturer
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT06757829 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 50 Years, studying Sickle Cell Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06757829 currently recruiting?
Yes, NCT06757829 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT06757829 trial being conducted?
This trial is being conducted at Dokki, Egypt.
Who is sponsoring the NCT06757829 clinical trial?
NCT06757829 is sponsored by Cairo University. The principal investigator is Ali Ismail, lecturer at Cairo University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.